Skip to main content
SpringerLink
Log in

Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration

  • OPHTHALMIC DISEASE
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Serum C-reactive protein (CRP), an important inflammatory marker, has been associated with age-related macular degeneration (AMD) in observational studies; however, the findings are inconsistent. It remains unclear whether the association between circulating CRP levels and AMD is causal. We used two-sample Mendelian randomization (MR) to evaluate the potential causal relationship between serum CRP levels and AMD risk. We derived genetic instruments for serum CRP levels in 418,642 participants of European ancestry from UK Biobank, and then conducted a genome-wide association study for 12,711 advanced AMD cases and 14,590 controls of European descent from the International AMD Genomics Consortium. Genetic variants which predicted elevated serum CRP levels were associated with advanced AMD (odds ratio [OR] for per standard deviation increase in serum CRP levels: 1.31, 95% confidence interval [CI]: 1.19–1.44, P = 5.2 × 10−8). The OR for the increase in advanced AMD risk when moving from low (< 3 mg/L) to high (> 3 mg/L) CRP levels is 1.29 (95% CI: 1.17–1.41). Our results were unchanged in sensitivity analyses using MR models which make different modelling assumptions. Our findings were broadly similar across the different forms of AMD (intermediate AMD, choroidal neovascularization, and geographic atrophy). We used multivariable MR to adjust for the effects of other potential AMD risk factors including smoking, body mass index, blood pressure and cholesterol; this did not alter our findings. Our study provides strong genetic evidence that higher circulating CRP levels lead to increases in risk for all forms of AMD. These findings highlight the potential utility for using circulating CRP as a biomarker in future trials aimed at modulating AMD risk via systemic therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–59.

    PubMed  Google Scholar 

  2. Friedman DS, O’Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–72.

    PubMed  Google Scholar 

  3. Klein R, Klein BE, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res. 1999;18(3):371–89.

    CAS  PubMed  Google Scholar 

  4. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the blue mountains eye study. Ophthalmology. 1995;102(10):1450–60.

    CAS  PubMed  Google Scholar 

  5. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):e106–16.

    PubMed  Google Scholar 

  6. Fritsche LG, Igl W, Bailey JNC, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–43. https://doi.org/10.1038/ng.3448.

    Article  CAS  PubMed  Google Scholar 

  7. Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Molins B, Romero-Vázquez S, Fuentes-Prior P, Adan A, Dick AD. C-reactive protein as a therapeutic target in age-related macular degeneration. Front Immunol. 2018;19(9):808.

    Google Scholar 

  9. Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45(4):433–9, 439e1–2.

    PubMed  Google Scholar 

  10. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291(6):704–10.

    CAS  PubMed  Google Scholar 

  12. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005;123(6):774–82.

    PubMed  Google Scholar 

  13. McGwin G, Hall TA, Xie A, Owsley C. The relation between C reactive protein and age related macular degeneration in the cardiovascular health study. Br J Ophthalmol. 2005;89(9):1166–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Wu KHC, Tan AG, Rochtchina E, et al. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study. Invest Ophthalmol Vis Sci. 2007;48(5):1983–8.

    PubMed  Google Scholar 

  15. Klein R, Knudtson MD, Klein BEK, et al. Inflammation, complement factor h, and age-related macular degeneration: the multi-ethnic study of Atherosclerosis. Ophthalmology. 2008;115(10):1742–9.

    PubMed  PubMed Central  Google Scholar 

  16. Hong T, Tan AG, Mitchell P, Wang JJ. A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol. 2011;56(3):184–94.

    PubMed  Google Scholar 

  17. Mitta VP, Christen WG, Glynn RJ, et al. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. JAMA Ophthalmol. 2013;131(4):507–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Yip JLY, Khawaja AP, Chan MPY, et al. Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPIC-Norfolk eye study. PLoS ONE. 2015;10(7):e0132565.

    PubMed  PubMed Central  Google Scholar 

  19. Despriet DDG, Klaver CCW, Witteman JCM, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296(3):301–9.

    PubMed  Google Scholar 

  20. Schaumberg DA, Christen WG, Kozlowski P, Miller DT, Ridker PM, Zee RYL. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47(6):2336–40.

    PubMed  PubMed Central  Google Scholar 

  21. Kim IK, Ji F, Morrison MA, et al. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol Vis. 2008;11(14):1487–95.

    Google Scholar 

  22. Cipriani V, Hogg RE, Sofat R, et al. Association of C-reactive protein genetic polymorphisms with late age-related macular degeneration. JAMA Ophthalmol. 2017;135(9):909–16.

    PubMed  PubMed Central  Google Scholar 

  23. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;12(362):k601.

    Google Scholar 

  24. Pingault J-B, O’Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet. 2018;19(9):566–80.

    CAS  PubMed  Google Scholar 

  25. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Loh P-R, Tucker G, Bulik-Sullivan BK, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Ligthart S, Vaez A, Võsa U, et al. Genome analyses of > 200,000 individuals identify 58 Loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018;103(5):691–706.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44(8):955–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–501.

    PubMed  Google Scholar 

  32. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.

    PubMed  PubMed Central  Google Scholar 

  33. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. EPIC- InterAct consortium. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543–52.

    PubMed  PubMed Central  Google Scholar 

  34. Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–89.

    PubMed  PubMed Central  Google Scholar 

  35. Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783–802.

    PubMed  PubMed Central  Google Scholar 

  36. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

    PubMed  PubMed Central  Google Scholar 

  37. Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30–42.

    PubMed  Google Scholar 

  38. Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251–60.

    PubMed  PubMed Central  Google Scholar 

  40. Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife [Internet]. 2018. https://doi.org/10.7554/eLife.34408.

    Article  Google Scholar 

  41. Sanderson E, Smith GD, Windmeijer F, Bowden J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings [Internet]. Int J Epidemiol. 2018. https://doi.org/10.1093/ije/dyy262.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Burgess S, Thompson DJ, Rees JMB, Day FR, Perry JR, Ong KK. Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer. Genetics. 2017;207(2):481–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734–9.

    PubMed  PubMed Central  Google Scholar 

  44. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2017. Available from: https://www.R-project.org/. Accessed 1 Apr 2019.

  45. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was conducted using the UK Biobank Resource (application number 25331). For the AMD datasets, all contributing sites and additional funding information are acknowledged in this publication: Fritsche et al. [6]; The International AMD Genomics consortium’s web page is: http://eaglep.case.edu/iamdgc_web/, and additional information is available on: http://csg.sph.umich.edu/abecasis/public/amd2015/. The AMD case-control datasets used for the analyses described in this manuscript were obtained from the NEI Study of Age-Related Macular Degeneration (NEI-AMD) Database found at https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001039.v1.p1 through dbGaP accession number 20740. Funding support for NEI-AMD was provided by the National Eye Institute. We would like to thank NEI-AMD participants and the NEI-AMD Research Group for their valuable contribution to this research. SM and AWH are supported by Australian National Health and Medical Research Council (NHMRC) Fellowships. XH is supported by the University of Queensland Research Training Scholarship and QIMR Berghofer PhD Top Up Scholarship. We acknowledge funding from NHMRC Grants [1116360, 1150144 and 1123248]. The authors thank all of the participants who took part in the UK Biobank and the International AMD Genomics Consortium and support staff who made this study possible. We thank Scott Wood, Xiaping Lin, and John Pearson from QIMR Berghofer for IT support.

Author information

Authors and Affiliations

  1. Statistical Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia

    Xikun Han, Jue-Sheng Ong, Jiyuan An, Puya Gharahkhani & Stuart MacGregor

  2. School of Medicine, University of Queensland, St Lucia, Brisbane, Australia

    Xikun Han

  3. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Alex W. Hewitt

  4. Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia

    Alex W. Hewitt

Authors
  1. Xikun Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jue-Sheng Ong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiyuan An
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alex W. Hewitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Puya Gharahkhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stuart MacGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xikun Han.

Ethics declarations

Conflict of interest

The authors have declared that no competing interests exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 28 kb)

Supplementary material 2 (DOCX 339 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, X., Ong, JS., An, J. et al. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration. Eur J Epidemiol 35, 139–146 (2020). https://doi.org/10.1007/s10654-019-00598-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-019-00598-z

Keywords

Search

Navigation